vs
Side-by-side financial comparison of BeOne Medicines Ltd. (ONC) and SEALED AIR CORP (SEE). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× SEALED AIR CORP). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 3.1%, a 1.3% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 2.6%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $257.7M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 2.7%).
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Sealed Air Corporation is a global provider of innovative packaging and protective solutions. Its core offerings include cushioning materials, food safety and preservation packaging, and sustainable waste-reducing packaging systems, serving retail, e-commerce, food and beverage, and industrial manufacturing markets worldwide.
ONC vs SEE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.4B |
| Net Profit | $66.5M | $43.8M |
| Gross Margin | 90.5% | 28.6% |
| Operating Margin | 12.4% | 11.4% |
| Net Margin | 4.4% | 3.1% |
| Revenue YoY | 32.8% | 2.6% |
| Net Profit YoY | 143.8% | 700.0% |
| EPS (diluted) | $0.05 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.1B | $1.4B | ||
| Q3 24 | $1.0B | $1.3B | ||
| Q2 24 | $929.2M | $1.3B | ||
| Q1 24 | $751.7M | $1.3B |
| Q4 25 | $66.5M | $43.8M | ||
| Q3 25 | $124.8M | $255.1M | ||
| Q2 25 | $94.3M | $93.1M | ||
| Q1 25 | $1.3M | $113.5M | ||
| Q4 24 | $-151.9M | $-7.3M | ||
| Q3 24 | $-121.3M | $91.7M | ||
| Q2 24 | $-120.4M | $98.3M | ||
| Q1 24 | $-251.2M | $82.0M |
| Q4 25 | 90.5% | 28.6% | ||
| Q3 25 | 86.1% | 29.8% | ||
| Q2 25 | 87.5% | 30.7% | ||
| Q1 25 | 85.2% | 30.9% | ||
| Q4 24 | 85.8% | 30.0% | ||
| Q3 24 | 83.0% | 30.1% | ||
| Q2 24 | 85.1% | 31.2% | ||
| Q1 24 | 83.4% | 30.3% |
| Q4 25 | 12.4% | 11.4% | ||
| Q3 25 | 11.5% | 13.8% | ||
| Q2 25 | 6.7% | 15.0% | ||
| Q1 25 | 1.0% | 14.5% | ||
| Q4 24 | -7.0% | 11.7% | ||
| Q3 24 | -12.0% | 13.9% | ||
| Q2 24 | -11.5% | 15.4% | ||
| Q1 24 | -34.8% | 14.0% |
| Q4 25 | 4.4% | 3.1% | ||
| Q3 25 | 8.8% | 19.0% | ||
| Q2 25 | 7.2% | 7.0% | ||
| Q1 25 | 0.1% | 9.0% | ||
| Q4 24 | -13.5% | -0.5% | ||
| Q3 24 | -12.1% | 6.9% | ||
| Q2 24 | -13.0% | 7.4% | ||
| Q1 24 | -33.4% | 6.2% |
| Q4 25 | $0.05 | $0.30 | ||
| Q3 25 | $0.08 | $1.73 | ||
| Q2 25 | $0.06 | $0.63 | ||
| Q1 25 | $0.00 | $0.77 | ||
| Q4 24 | $-0.10 | $-0.05 | ||
| Q3 24 | $-0.09 | $0.63 | ||
| Q2 24 | $-0.09 | $0.67 | ||
| Q1 24 | $-0.19 | $0.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5B | $344.0M |
| Total DebtLower is stronger | $836.4M | $3.3B |
| Stockholders' EquityBook value | $4.4B | $1.2B |
| Total Assets | $8.2B | $7.0B |
| Debt / EquityLower = less leverage | 0.19× | 2.65× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.5B | $344.0M | ||
| Q3 25 | $4.0B | $282.5M | ||
| Q2 25 | $2.8B | $354.4M | ||
| Q1 25 | $2.5B | $335.2M | ||
| Q4 24 | $2.6B | $371.8M | ||
| Q3 24 | $2.7B | $386.0M | ||
| Q2 24 | $2.6B | $388.6M | ||
| Q1 24 | $2.8B | $352.8M |
| Q4 25 | $836.4M | $3.3B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.4B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $4.4B | $1.2B | ||
| Q3 25 | $4.1B | $1.2B | ||
| Q2 25 | $3.8B | $953.1M | ||
| Q1 25 | $3.5B | $797.9M | ||
| Q4 24 | $3.3B | $624.5M | ||
| Q3 24 | $3.4B | $771.2M | ||
| Q2 24 | $3.4B | $650.1M | ||
| Q1 24 | $3.4B | $598.3M |
| Q4 25 | $8.2B | $7.0B | ||
| Q3 25 | $7.6B | $7.1B | ||
| Q2 25 | $6.3B | $7.2B | ||
| Q1 25 | $5.8B | $7.0B | ||
| Q4 24 | $5.9B | $7.0B | ||
| Q3 24 | $5.8B | $7.3B | ||
| Q2 24 | $5.7B | $7.3B | ||
| Q1 24 | $5.7B | $7.2B |
| Q4 25 | 0.19× | 2.65× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | 4.18× | ||
| Q1 25 | — | 5.26× | ||
| Q4 24 | — | 6.72× | ||
| Q3 24 | — | 5.62× | ||
| Q2 24 | — | 6.81× | ||
| Q1 24 | — | 7.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $417.3M | $293.6M |
| Free Cash FlowOCF − Capex | $379.8M | $257.7M |
| FCF MarginFCF / Revenue | 25.4% | 18.5% |
| Capex IntensityCapex / Revenue | 2.5% | 2.6% |
| Cash ConversionOCF / Net Profit | 6.28× | 6.70× |
| TTM Free Cash FlowTrailing 4 quarters | $941.7M | $458.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $417.3M | $293.6M | ||
| Q3 25 | $402.6M | $165.9M | ||
| Q2 25 | $263.6M | $136.6M | ||
| Q1 25 | $44.1M | $31.9M | ||
| Q4 24 | $75.2M | $244.2M | ||
| Q3 24 | $188.4M | $170.5M | ||
| Q2 24 | $-95.6M | $188.2M | ||
| Q1 24 | $-308.6M | $125.1M |
| Q4 25 | $379.8M | $257.7M | ||
| Q3 25 | $354.5M | $119.6M | ||
| Q2 25 | $219.8M | $93.2M | ||
| Q1 25 | $-12.3M | $-12.0M | ||
| Q4 24 | $-17.3M | $185.1M | ||
| Q3 24 | $54.7M | $115.2M | ||
| Q2 24 | $-205.5M | $129.5M | ||
| Q1 24 | $-465.1M | $78.0M |
| Q4 25 | 25.4% | 18.5% | ||
| Q3 25 | 25.1% | 8.9% | ||
| Q2 25 | 16.7% | 7.0% | ||
| Q1 25 | -1.1% | -0.9% | ||
| Q4 24 | -1.5% | 13.6% | ||
| Q3 24 | 5.5% | 8.6% | ||
| Q2 24 | -22.1% | 9.7% | ||
| Q1 24 | -61.9% | 5.9% |
| Q4 25 | 2.5% | 2.6% | ||
| Q3 25 | 3.4% | 3.4% | ||
| Q2 25 | 3.3% | 3.3% | ||
| Q1 25 | 5.0% | 3.5% | ||
| Q4 24 | 8.2% | 4.4% | ||
| Q3 24 | 13.3% | 4.1% | ||
| Q2 24 | 11.8% | 4.4% | ||
| Q1 24 | 20.8% | 3.6% |
| Q4 25 | 6.28× | 6.70× | ||
| Q3 25 | 3.22× | 0.65× | ||
| Q2 25 | 2.79× | 1.47× | ||
| Q1 25 | 34.71× | 0.28× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | — | 1.91× | ||
| Q1 24 | — | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ONC
Segment breakdown not available.
SEE
| Protective Segment | $1.1B | 78% |
| Other | $292.0M | 21% |
| Pension Plans Defined Benefit | $7.9M | 1% |
